N-(3-bromobenzyl)-1-propanamine hydrochloride, 95.0%, 5g

4-(2-Fluorophenyl)-1h-pyrazole, 97%, 500mg

(3-((Benzyloxy)carbonyl)-5-nitrophenyl)boronic acid, 95.0%, 5g

4-TERT-BUTYL 2-METHYL 2-METHYLMORPHOLINE-2,4-DICARBOXYLATE, 95.0%, 250mg

N-Fmoc-8-Aminooctanoic acid, 95.0%, 25g

4-Bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine, 95.0%, 500mg

[1-(1-methyl-1H-benzimidazol-2-yl)ethyl]amine dihydrochloride hydrate, 95.0%, 1g

2-Amino-5-chloropyridin-3-ol, 95.0%, 100g

(R)-1-CYCLOPENTYLETHANAMINE HCL, 95.0%, 5g

D-1-Fmoc-Nipecotic acid, 97.0%, 2.5g

tert-Butyl (R)-2-ethynyl-2-methylpyrrolidine-1-carboxylate, 98%, 500mg

(S)-1-(2,5-DICHLOROPHENYL)ETHAN-1-AMINE, 95%, 50mg

4,4'-Dimethoxytrityl chloride, min 98%, for synthesis, 5 g, glass packaging